The Actual Cost of COVID-19
In between conspiracy and accounting resides the truth about the financial impact of COVID-19. As a systemic risk, it is ...
Much Ado About Aduhelm
The data supporting Aduhelm are scant at best. But that did not stop its manufacturer from releasing additional data, showing ...
Vaccine Hesitancy is Complicating Physicians’ Obligation to Respect Patient Autonomy
Autonomy is one of the pillars of bioethics, and it is the notion that the patient has the ultimate decision-making ...
The COVID-19 Pandemic Offers an Opportunity to Make a Healthy Shift in Body Ideals
The COVID-19 pandemic has changed everyday life for many people in both trivial and profound ways, including how they look ...
What is the New COVID-19 Variant BA.2?
While the origin of BA.2 is still unclear, it has become the dominant strain in many countries, including India, Denmark ...
Abortion Pills are Just as Safe to Prescribe Online as After an In-person Exam
When medication abortion, or abortion with pills, was introduced to the U.S. in 2000, it offered a more accessible option ...
Why Pregnant People Should Get Vaccinated For COVID-19
Pregnancy is often a time of sweet anticipation. But the ongoing pressure to make the right decisions for the health ...
Four the Love of Vaccines
The FDA recently received requests to approve a second COVID booster. At the same, it is unsealing documents that were ...
Venture Growth is not Healthcare Growth
Growth is a curious thing. We know it when we see it, but we find it hard to replicate. This ...
A Fleeting Perception of Data
Data only tells one part of the story when it comes to understanding health policy. The full story is found ...
From Healthy Births to Sustainable Management
Researchers have observed that the offspring of mice and other animals derive health benefits from passing through the vagina.
Is Omicron Mother Nature’s Variant?
It spreads efficiently and quickly, it generally causes milder disease than previous variants and it may confer strong protection against ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more